oa Advances in Platinum Complex Cancer Chemotherapy

References

1. McKeage M. J., Higgins J. D. III, and Kelland L. R. Br. J. Cancer, 1991, 64, 788 [Google Scholar]
2. Horwich A. Br. J. Cancer, 1989, 59, 156 [Google Scholar]
3. Neijt J. P., ten Bokkel Huinink W. W., van der Burg M. E. L., van Oosterom A. T., Willemse P. H. B., Vermorken J. B., van Lindert A. C. M., Heintz A. P. M., Aartsen E., van Lent M., Trimbos J. B., and de Meijer A. J. Eur. J. Cancer, 1991, 27, 1367 [Google Scholar]
4. Smith I. E., and Talbot D. C. Br. J. Cancer, 1992, 65, 787 [Google Scholar]
5. Cubeddu L. X., Hoffman I. S., Fuenmayor N. T., and Finn A. L. N. Engl. J. Med., 1990, 322, 810 [Google Scholar]
6. Smith D. B., Newlands E. S., Rustin G. J. S., Begent R. H. J., Howells N., McQuade B., and Bagshawe K. D. Lancet, 1991, 338, 487 [Google Scholar]
7. Gerritsen van der Hoop R., Vecht C. J., van der Burg M. E. L., Elderson A., Boogerd W., Heimans J. J., Vries E. P., van Houwelingen J. C., Jennekens F. G. I., Gispen W. H., and Neijt J. P. N. Engl. J. Med., 1990, 322, 89 [Google Scholar]
8. Bissen D., Kunkeler L., Zwanenberg L., Paul J., Gray C., Swan I. R. C., Kerr D. J., and Kaye S.B. Br. J. Cancer, 1990, 62, 655 [Google Scholar]
9. Advanced Ovarian Trialists Group,Br. Med. J., 1991, 303, 884 [Google Scholar]
10. Klastersky J., Sculier J. P., Lacroix H., Dabouis D., Bureau G., Libert P., Richez M., Ravez P., Vandermoten G., Thiriaux J., Cordier R., Finet C., Berchier M. C., Sergysels R., Mommem P., and Paesmans M. J. Clin. Oncol, 1990, 8, 1556 [Google Scholar]
11. Alberts D. S., Green S., Hannigan E. V., O’Toole R., Stock-Novach D., Anderson P., Surwit E. A., Malvlya V. K., Nahlas W. A., and Jolles C. J. J. Clin. Oncol, 1992, 10, 706 [Google Scholar]
12. Calvert A. H., Newell D. R., Gumbrell L., O’Reilly S., Burnell M., Boxall F. E., Siddik Z. H., Judson I. R., Gore M. E., and Wiltshaw E. J. Clin. Oncol., 1989, 7, 1748 [Google Scholar]
13. Shea T. C., Mason J. R., Storniolo A. M., Newton B., Breslin M., Mullen M., Ward D. M., Miller L., Christian M., and Taetle R. J. Clin. Oncol, 1992, 10, 464 [Google Scholar]
14. Jodreil D. I., Egorin M. J., Canetta R. C., Langenberg P., Goldbloom E. P., Burrough J. N., Goodlow J. L., Tan S., and Wiltshaw E. J. Clin. Oncol, 1992, 10, 520 [Google Scholar]
15. McKeage M. J., Kelland L. R., Neidle S., and Waring M. J. Molecular Aspects of Drug-DNA Interactions,” ed. Macmillan, 1992, 1, in press [Google Scholar]
16. Harrap K. R., Jones M., Siracky J., Pollard L., and Kelland L. R. Ann Oncol, 1990, 1, 65 [Google Scholar]
17. Hills C. A., Kelland L. R., Abel G., Siracky J., Wilson A. P., and Harrap K. R. Br. J. Cancer., 1989, 59, 527 [Google Scholar]
18. Kelland L. R., Mistry P., Abel G., Loh S. Y., O’Neill C. F., Murrer B. A., and Harrap K. R. Cancer Res., 1992, 52, 3857 [Google Scholar]
19. Andrews P. A., and Howell S. B. Cancer Cells, 1990, 2, 35 [Google Scholar]
20. Bernal S. D., Speak J. A., Boeheim K., Dreyfuss A. I., Wright J. E., Teicher B. A., Rosowski A., Tsao S. W., and Wong Y.C. Mol. Cell Biochem., 1990, 95, 61 [Google Scholar]
21. Kawai K., Kamatani N., Georges E., and Ling V. J. Biol. Chem., 1990, 265, 13137 [Google Scholar]
22. Howell S. B. “Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy”, ed. Plenum Press, New York, 1991 [Google Scholar]
23. Kelland L. R., Murrer B. A., Abel G., Giandomenico C. M., Mistry P., and Harrap K. R. Cancer Res., 1992, 52, 822 [Google Scholar]